[Low rectal cancer: conservative approach integrating radiotherapy].

Abstract:

:During the past two decades, the general acceptance of the surgical conservative treatments in tumors such as breast cancer, bone and soft tissue sarcoma, represents one of the significant steps achieved in the treatment of solid tumors. For low rectal cancer, abdominoperineal resection is considered the standard treatment. However, conservative treatments (mono- or multimodality) seem to be as effective, provided that the selection of patients and the choice of the treatment are adequate. This opens a real perspective in favour of conservative treatments resulting already in a restriction in the indications of abdominoperineal resection. In those conservative strategies, radiotherapy has often been used, and some authors consider it essential in several clinical situations.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Allal AS

subject

Has Abstract

pub_date

1996-03-01 00:00:00

pages

189-96

issue

3

eissn

0007-4551

issn

1769-6917

pii

0007-4551(96)85119-8

journal_volume

83

pub_type

杂志文章,评审
  • [Radiosurgery by linear accelerators in the treatment of 84 arteriovenous malformations].

    abstract::We have treated in 1990 and 1991, 84 arteriovenous malformations (AVMs) by radiosurgery. Irradiation was realized by 5 to 7 arcs with 15 MV X rays circular minibeams of a GE-CGR Saturne 43 Linac diameter, at 100 cm 6 to 20 mm; the Betti arm chair and the Talairach frame. The prescribed peripheral dose containing the n...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Schlienger M,Merienne L,Lefkopoulos D

    更新日期:1995-12-01 00:00:00

  • [Inhibitors of bone marrow stem cells proliferation. Possible applications during chemotherapy (author's transl)].

    abstract::An inhibitor of bone marrow stem cell (CFU-S) proliferation, prepared from fetal calf marrow, was administered to mice during sequential treatments with Cytosine Arabinoside. Results show that the percentage of CFU-S survival is significantly increased when the inhibitor is given simultaneously with the drug. A purifi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guigon M,Frindel E

    更新日期:1981-01-01 00:00:00

  • [Opioid switch and change of route of administration in cancer patients treated by morphine].

    abstract::This paper reviewed the 2002 guidelines established by the National Federation of Cancer Centres. A group of experts nominated by the 3 French Societies involved in the treatment of cancer pain (AFSOS, SFAP, SFETD), established new guidelines ratios for morphine switching and/or changing of route of administration, in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2018.06.011

    authors: Michenot N,Rostaing S,Baron L,Faure S,Jovenin N,Hubault P,Delorme T,Collin E,Filbet M,Chvetzoff G,Delorme C,Minello C,Magnet M,Ammar D,Krakowski I,Poulain P

    更新日期:2018-11-01 00:00:00

  • [Importance of a multidisciplinary approach to metastatic cancer of the rectum].

    abstract::Management of rectal cancers with synchronous metastasis is difficult. We evaluated in 23 patients a combination of pelvic radiotherapy at the dose of 45 Gy in 5 weeks and 25 fractions with chemotherapy by 5-fluorouracil (350 mg/m2/day) and folinic acid (20 mg/m2/day) for 5 days at the time of the first and the fifth ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mitry E,Pompili PL,Rougier P,Toma C,Ducreux M,Lusinchi A,Elias D,Fabri MC,Bourhis J,Kac J,Eschwege F,Lasser P

    更新日期:1998-08-01 00:00:00

  • An ethics dilemma: when parents and doctors disagree on the best treatment for the child.

    abstract::The increasing complexity of present day medicine--with highly effective and yet risky treatments, individual and collective expectations, and evolving ideological and cultural landmarks--often gives rise to difficult ethical problems. Specific meetings are valuable for understanding such problems, acquiring the relev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Oppenheim D,Brugières L,Corradini N,Vivant F,Hartmann O

    更新日期:2004-09-01 00:00:00

  • The physician data query (PDQ) cancer information system.

    abstract::PDQ is an online database that provides information about the prognosis and treatment of all major types of cancer. It represents a major effort by the NCI to communicate advances in cancer treatment using computer technology, and serves as a major component of the Institute's program to reduce cancer mortality nation...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hubbard SM

    更新日期:1987-01-01 00:00:00

  • [Early adjuvant intraportal chemotherapy with 5-fluorouracil after hepatic resection of colorectal metastasis: a preliminary clinical and pharmacokinetic study].

    abstract::Intraportal continuous infusion of 5-FU (600 mg/m2/24 h during 7 days) was administered in the immediate postoperative course of 6 consecutive patients with colorectal metastases resected for cure (one segmentectomy and 5 nonanatomical local resections). One month later, a systemic continuous infusion of 5-FU was deli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Seitz JF,Aubert C,Giovannini M,Delpero JR,Houvenaeghel G,Guerinel G,Carcassonne Y

    更新日期:1989-01-01 00:00:00

  • [Locoregional recurrence of ORL cancer: the place of surgery].

    abstract::Surgery of locoregional failures is mainly represented by salvage surgery after radiotherapy. Due to progress of radiotherapy, especially modification of fractionation and association with chemotherapy, the problem of salvage surgery is nowadays emphasized. Despite the reduction of postoperative mortality and morbidit...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Julieron M,Temam S

    更新日期:2004-11-01 00:00:00

  • [Treatment with cytokines of metastatic kidney cancer: the Lyon experience].

    abstract::Between October 1987 and June 1992, 244 patients with metastatic renal carcinoma were referred to our Institute. One hundred and sixty-nine were included in immunotherapy protocols. The 40 most recent patients were included in the ongoing multicentric randomised Crecy study. The previous patients were treated with IL2...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Négrier S,Mercatello A,Coronel B,Lanier F,Merrouche Y,Bret M,Blay JY,Lasset C,Thiesse P,Carrie C

    更新日期:1993-07-01 00:00:00

  • [The management of the metastatic disease by the surgeons].

    abstract::The high rate of recurrence after apparently complete surgery and/or complete clinical response to chemotherapy implies that most patients have undetected minimal residual disease. Novel techniques such as laparoscopic or laparotomic fluorescence may prove to be crucial in reassessing the definition of primary outcome...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1730

    authors: Mery E,Golzio M,Thibault B,Ferron G,Querleu D,Delord JP,Couderc B

    更新日期:2013-04-01 00:00:00

  • Herpes virus production as a marker of repair in ultraviolet irradiated human skin cells of different origin.

    abstract::When confluent human skin cultures are ultraviolet (UV)-irradiated before infection with Herpes Simplex type 1 virus (HSV), their capacity to support virus growth is impaired. When the time interval between UV-exposure and infection is increased up to 36 hours, different recoveries of HSV production capacity are obser...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coppey J,Moreno G,Nocentini S

    更新日期:1978-01-01 00:00:00

  • [Biological bases for individualising prescriptions in oncology: the germline genome].

    abstract::Sequencing the human genome brings new tools for the individualisation of cancer chemotherapy, especially thanks to the identification of polymorphisms of genes involved in anticancer drug metabolism or activity (pharmacogenetics). A few functional polymorphisms have been known for a long time (thiopurine methyltransf...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0722

    authors: Robert J,Le Morvan V

    更新日期:2008-10-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [Irinotecan for the treatment of metastatic colorectal cancer].

    abstract::In a dozen years of development, irinotecan (CPT11) became one of major therapeutics in the taking care of the metastatic colorectal cancer (CCRM). First used in monotherapy every three weeks, irinotecan has been later developed in association with 5FU and folinic acid according to two modalities of administration (bo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Assenat E,Duffour J,Ychou M

    更新日期:2006-05-01 00:00:00

  • [The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer].

    abstract::Based on the observation of a high incidence of breast cancer in the upper outer quadrant adjacent to the usual area of application of deodorants and/or antiperspirants, several scientific teams have advanced the hypothesis of a possible link between antiperspirants and breast cancer. The possibility of the involvemen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0679

    authors: Namer M,Luporsi E,Gligorov J,Lokiec F,Spielmann M

    更新日期:2008-09-01 00:00:00

  • [The Stockholm preoperative radiotherapy of operable breast cancer. Preliminary report].

    abstract::The 4 year results of a prospective clinical trial on the treatment of operable breast cancer, comparing the effects of preoperative radiotherapy followed by surgery with those of surgery followed or not by postoperative radiotherapy are presented for patient groups of approximately 100 each. At 4 years 85 per cent su...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wallgren A,de Schryver A,Wasserman J

    更新日期:1977-01-01 00:00:00

  • [Biology of small-cell bronchogenic carcinoma: recent advances].

    abstract::In the last ten years considerable progress has been made in small-cell lung carcinoma (SCLC) biology, along with the technical progress made in molecular biology. This progress now allows us to propose a model for the genesis and the development of this type of tumor. Tobacco, the principal causal factor plays a dual...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Levy R,Andrieu JM,Even P

    更新日期:1992-01-01 00:00:00

  • [Communication process in consultation of patients with incurable disease: a prospective study].

    abstract::Patients wish to be fully informed about their health, but some information and its disclosure may pose special challenges depending on the severity of the illness. This prospective observational study investigates the content of information about the disease and treatment, as well as the process by which information ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1530

    authors: Marcoux I

    更新日期:2012-02-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [Juvenile nasopharyngeal carcinoma: anatomoclinic, biologic, therapeutic and evolutive aspects].

    abstract::Nasopharyngeal carcinoma (NPC) represents one of the most frequent epithelial tumours of the child in intermediate risk regions. In the Maghreb, it represents the first cancer of teenagers of 15-20 years old. The Epstein Barr virus (EBV) is the most important etiologic factor. Its role in the pathogeneses of NPC has b...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1087

    authors: Toumi N,Frikha M,Siala W,Khabir A,Karray H,Boudawara T,Gargouri RM,Ghorbel M,Daoud J

    更新日期:2010-04-01 00:00:00

  • [Training of pharmacy personnel in the management of a centralized unit: the Oncolor network experience].

    abstract::The network of cancer care units in Lorraine area (Oncolor) developed management training for people working in chemotherapy units, and cytotoxic drug preparation. The programme was framed both for staff of executives (pharmacists), and technicians. Firstly, comparison between practices and theoretical recommendations...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Henn-Ménétré S,Noirez V,Husson J,Vallance C,Lestreit JM,Llorens AM,May I,Grandhaye JP,Bey P

    更新日期:2003-10-01 00:00:00

  • Immunothérapie des glioblastomes.

    abstract:IMMUNOTHERAPY IN GLIOBLASTOMAS:Targeting the immune system as a therapeutic strategy in solid tumors has shown great efficacy in various tumor types. However the role and success of this approach in glioblastomas remain to be determined. Recent studies demonstrated that central nervous system is no longer considered as...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(18)30391-6

    authors: Baldini C,Romano PM,Varga A,Champiat S,Dumont S,Dhermain F,Louvel G,Marabelle A,Postel-Vinay S,Angevin E,Gazzah A,Ribrag V,Bahleda R,Michot JM,Hollebecque A,Soria JC,Massard C

    更新日期:2018-12-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].

    abstract::At the time of diagnosis, central nervous system (CNS) involvement is identified in less than 10% of adult acute lymphoblastic leukemia (ALL). Long-term disease-free survival can be achieved in these patients. CNS disease at presentation does not appear to be an independent poor prognostic factor. In CNS leukemia, inn...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0645

    authors: Thomas X,Pavan L,Le QH

    更新日期:2008-07-01 00:00:00

  • [Management of enzalutamide, a new hormonal therapy].

    abstract::Enzalutamide (MDV3100) is a non-steroidal antiandrogen of second generation that has shown efficacy in metastatic castration-resistant prostate cancer (mCRPC). The study AFFIRM demonstrated a statistically significant increase in overall survival among patients who have progressed following a docetaxel chemotherapy. B...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1880

    authors: Beuzeboc P,Benderra MA,de La Motte Rouge T

    更新日期:2014-01-01 00:00:00

  • [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].

    abstract::Despite surgery, post-operative irradiation and adjuvant conventional chemotherapy, prognosis of high-grade gliomas remains poor. Carmustine (BCNU) has been shown to have limited activity at conventional dosage but is still the standard chemotherapy. Activity of chemotherapy is limited by the blood-brain barrier imper...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Linassier C,Destrieux C,Benboubker L,Alcaraz L,Bergemer-Fouquet AM,Jan M,Calais G,Colombat P

    更新日期:2001-09-01 00:00:00

  • [Adjuvant treatment of colon cancer MOSAIC study's main results].

    abstract::Oxaliplatin in combination with 5-fluorouracil/leucovorin (LV5FU) improves the response rate and survival of patients with metastatic colorectal cancer. The objective of the Mosaic study was to evaluate the efficacy of this association in the adjuvant treatment of stage II and III colon cancer. This international stud...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: André T,Tournigand C,Achille E,Tubiana-Mathieu N,Lledo G,Raoul Y,Carola E,Flesch M,Muron T,Boutan-Laroze A,Guérin Meyer V,Boaziz C,Maigre M,Ganem G,Mousseau M,Mounedji-Boudiaf L,de Gramont A

    更新日期:2006-02-01 00:00:00

  • [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

    abstract:INTRODUCTION:The last years are marked by the emergence of new molecules for the treatment of metastatic cutaneous melanoma with a significant benefit on the survival. Besides, some techniques are in development for the loco-regional treatment of the metastatic sites, bringing new therapeutic perspectives. However, the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1684/bdc.2013.1868

    authors: Sassolas B,Mourrégot A,Thariat J,Tiffet O,Dygai-Cochet I,Mirabel X,Truc G,Cupissol D,Modiano P,Combemale P,Bedane C,Derrey S,Lamant L,Lubrano V,Siegrist S,Rougé-Bugat MÈ,Mazeau-Woynar V,Verdoni L,Planchamp F,Leccia

    更新日期:2014-01-01 00:00:00

  • [Tumor-stroma interactions].

    abstract::It is widely accepted that the development of carcinoma is not only due to somatic mutations in epithelial cells but also is influenced by the tumor microenvironment ie the stroma. The different stroma components produced growth factors, cytokines, the extra cellular matrix and also participated to the recruitment of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0560

    authors: Billottet C,Jouanneau J

    更新日期:2008-01-01 00:00:00

  • [Medico-economical assessment in cancerology].

    abstract::In recent studies, the economic criteria has begun to be integrated to the appraisal in cancerology. The question asked by the economist can be framed as follows: what incremental cost should the collectivity or the health insurance system consent, in order to improve the care of cancer patients? This involves first t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lebrun T,Selke B,Bercez C,Bonneterre ME,Lenne X,Sailly JC,Bonneterre J

    更新日期:1997-05-01 00:00:00